1. Home
  2. NVAX vs SPNS Comparison

NVAX vs SPNS Comparison

Compare NVAX & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • SPNS
  • Stock Information
  • Founded
  • NVAX 1987
  • SPNS 1982
  • Country
  • NVAX United States
  • SPNS Israel
  • Employees
  • NVAX N/A
  • SPNS N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • SPNS Computer Software: Prepackaged Software
  • Sector
  • NVAX Health Care
  • SPNS Technology
  • Exchange
  • NVAX Nasdaq
  • SPNS Nasdaq
  • Market Cap
  • NVAX 2.0B
  • SPNS 1.9B
  • IPO Year
  • NVAX 1995
  • SPNS 1992
  • Fundamental
  • Price
  • NVAX $9.76
  • SPNS $38.02
  • Analyst Decision
  • NVAX Buy
  • SPNS Buy
  • Analyst Count
  • NVAX 6
  • SPNS 3
  • Target Price
  • NVAX $17.83
  • SPNS $41.67
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • SPNS 62.4K
  • Earning Date
  • NVAX 11-07-2024
  • SPNS 11-11-2024
  • Dividend Yield
  • NVAX N/A
  • SPNS 1.52%
  • EPS Growth
  • NVAX N/A
  • SPNS 20.58
  • EPS
  • NVAX N/A
  • SPNS 1.23
  • Revenue
  • NVAX $987,667,000.00
  • SPNS $532,613,000.00
  • Revenue This Year
  • NVAX N/A
  • SPNS $9.56
  • Revenue Next Year
  • NVAX N/A
  • SPNS $7.14
  • P/E Ratio
  • NVAX N/A
  • SPNS $30.45
  • Revenue Growth
  • NVAX N/A
  • SPNS 8.37
  • 52 Week Low
  • NVAX $3.53
  • SPNS $24.39
  • 52 Week High
  • NVAX $23.86
  • SPNS $41.22
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • SPNS 57.65
  • Support Level
  • NVAX $9.52
  • SPNS $36.20
  • Resistance Level
  • NVAX $10.63
  • SPNS $37.62
  • Average True Range (ATR)
  • NVAX 0.57
  • SPNS 0.71
  • MACD
  • NVAX -0.12
  • SPNS 0.08
  • Stochastic Oscillator
  • NVAX 9.97
  • SPNS 65.43

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

Share on Social Networks: